Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nice company post.....
My money is on RCA as our contributing FDA expert and wealth of FDA PMA approval experience. Check out their experience in internal and external process audit.
$5-$10++
https://www.rcainc.com/medical-device/regulatory-affairs/new-product-approval-support/
https://www.rcainc.com/medical-device/compliance-assurance/audits/
Why would the CEO Brian Thom even mention "Separately, UHP expects to file its financial report for the third quarter of 2022 on Form 10-Q no later than November 14th. The report will show that the company generated modest commercial revenue for the first times since 2019, reflecting its reengagement with customers in the U.S. 510k market as well in certain international markets,"
The efficay of Hemostyp gauze is proven and supported with clinical tests, third party reviews and now commercial sales. Enough for me to determine the potential is high for FDA approval, merger or partner production agreement in the near term. Optimism?
$5-$10++
NEWS!
United Health Products Provides Update on FDA PMA Application
9:00 AM ET 10/31/22 | GlobeNewswire
United Health Products Provides Update on FDA PMA Application
Mesquite, NV, Oct. 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company's FDA Premarket Approval application and financial reporting calendar.
As previously disclosed in its press release of September 6th, UHP continues to assemble required documentation and test its manufacturing process to complete its FDA application for Class III Premarket Approval of its hemostatic gauze product. UHP, in collaboration with its contract manufacturing partner, have produced rolls of test product and are currently performing physical and chemical evaluations. Concurrently, UHP is completing its audit and assessment of the partner's manufacturing operation to confirm adherence to FDA requirements. The company expects to complete these tasks and work with its FDA consultant to draft and submit a revised application that is fully responsive to the Administration's earlier comments, prior to November 22nd. There can be no assurance that the company's PMA application will be approved.
Separately, UHP expects to file its financial report for the third quarter of 2022 on Form 10-Q no later than November 14th. The report will show that the company generated modest commercial revenue for the first time since 2019, reflecting its reengagement with customers in the U.S. 510k market as well in certain international markets.
Nice to see a gain of 33% in the last week from the bottom of .24 to Friday's close at .32. Sure it may not be based upon news that can be verified but any gain is a good gain! Tells me more shareholders have optimism the pps is headed up!
$5-$10++
Patience and so lets just keep the momentum moving forward. Buys are exceeding sells driving the pps up I believe. Hopefully someone can post the short sell numbers possibly from Philippe? Meanwhile hopefully we see a pr or FDA news?
$5-$10++
Not sure what your information and question are based upon but penny's are notoriously manipulated. Generally penny's are sold at year end for tax losses but the statement "Where penny stocks start to go on the rise" sounds baseless?
No offence!
$5-$10+
Best guess what is occurring today? Market open with a 600 share then a 100 followed by 1000 and a 67 share sale and now an 825 buy? Hmmm just no one willing to buy or better guess sell. Watch the attempt at a bating manipulation. How about a pr UEEC?
$5-$10++
https://www.fda.gov/Medical-Devices
https://www.fda.gov/medical-devices/workshops-conferences-medical-devices/webinar-computer-software-assurance-production-and-quality-system-software-draft-guidance-10272022
As I recall at some point UEEC provided the FDA with a third party engineer prepared software review and now we see technical guidance. This could have been predicated upon the UEEC hemostyp system device design or lack of?
$5-$10++
Interesting information or just a coincidence but...............
Webinar - Computer Software Assurance for Production and Quality System Software Draft Guidance
https://www.fda.gov/medical-devices/workshops-conferences-medical-devices/webinar-computer-software-assurance-production-and-quality-system-software-draft-guidance-10272022
https://www.fda.gov/Medical-Devices
Select the software first square and you see the 10/27 webinar for production and software related guidance!
"The FDA believes that applying a risk-based approach to computer software used as part of medical device production or the quality system would better focus manufacturers' assurance activities to help ensure product quality while helping to fulfill the validation requirements of 21 CFR?820.70(i)."
Timing is everything!
JMO this may be spot on for our current FDA request?
$5-$10++
With short interest really declining I see the POS shorts are running for cover!
SHORT INTEREST
DATE SHORT INTEREST % CHANGE AVG. DAILY SHARE VOL DAYS TO COVER SPLIT NEW ISSUE
09/30/2022 103,043 -6.16 195,368 1 No No
09/15/2022 109,806 -6.27 89,023 1 No No
08/31/2022 117,155 2.68 229,174 1 No No
08/15/2022 114,102 -18.66 259,166 1 No No
07/29/2022 140,285 5.47 262,974 1 No No
07/15/2022 133,005 -8.33 303,439 1 No No
06/30/2022 145,085 18.95 312,762 1 No No
06/15/2022 121,967 2.78 389,559 1 No No
05/31/2022 118,668 -17.67 210,184 1 No No
05/13/2022 144,140 5.22 330,380 1 No No
$5-$10++
Spot on! My $5000 I spent today bot me 20000 shares!
$5-$10+
To be specific I received the following email....."Dear United Health Products Shareholders and Followers, I no longer represent United Health Products. For further information regarding the company please contact Brian Thom at 475 755 1005."
Personally Phillippe Niemetz has always replied to any questions I posed without divulging or providing any information that could not be disclosed according to SEC rules and protocol. Thanks for your help Philippe.
We have no basis to interpret this as positive or negative news.
$5-$10+
Just contemplate when something happens and the price runs up past $1. to inevilabley be sold at $5+ you will have a 1700%+ gain!
.29 is a joke!
$5-$10+
Timing is everything and it doesn't take a genius or even a fraud short to see the stock is oversold and way undervalued.....Many eyes on the company news......
https://seekingalpha.com/symbol/UEEC
$5-$10++
Not guessing just deductive reasoning based upon what the CEO Brian Thom states in his pr of 9/6/22........"The company’s manufacturing equipment will commence production, allowing for the completion of Standard Operating Procedure and Design Control documentation, and the development of the Design Transfer process that will transfer detailed product design information to the manufacturing partner. It is anticipated that the completion of the audit process, establishment and inspection of gauze production, drafting of associated documentation, and testing of product to ensure conformance with previous product specifications will be completed within 60 days. In the interim, the company will continue to provide updates on achievement of milestones in this process."
Take it or leave it but yet something of interest compared to what else is being posted on the board!
$5-$10++
CEO Brian Thom will likely announce the prospectus filed Friday 9/23 with a Monday pr and announce this funding will initiate the production and manufacturing phase to meet FDA information requests. IMO!
$5-$10++
https://www.sec.gov/Archives/edgar/data/1096938/000147793222007149/ueec_424b3.htm
Show me the money! Our CEO is moving to do just that and more! "The proceeds of any sale of common stock to White Lion will be used for general corporate purposes including the establishment of a manufacturing operation for the company’s HemoStyp hemostatic gauze product and the completion of all remaining elements of the FDA Premarket Approval application, and to advance the development of powder and gel formats of the company’s patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent." We are about to advance on some crazy volume and an incredible ride!
$5-$10++
Kind of like some posts on this board ZERO -0- VALUE
$$TILLABELIEVER$$
F the short sellers bottom line! Total manipulation should be fined and banned by SEC! Get off your arse SEC and do your job!
$TILLABELIEVER$$
$1.+
Just the FACTS! Keith Nalepka stated 975000 Actipatch units to be purchased!
$TILLABELIEVER$$
$TILLABELIEVER$$ Revenues will drive the pps!
FWIW I don't recall that Keith was asked or addressed a buyout, merger or other type of acquisition! Hopefully the future will bring some interest from a big pharm or other market player!
$TILLABELIEVER$$
Just to correct your assertion "they are not going to warehouse 975,000 units." and Keith did not say warehouse but an INITIAL commitment up to by 1 (One distributor network).THINK BEFORE YOU SPEAK!
$TILLABELIEVER
Please disregard those with an agenda that post fake meaningless news!
Biel is FDA approved and as Keith Nalepka stated revenues from 975,000 orders will soon lift the share price up!
$TILLABELIEVER$
$TILLABELIEVER$$
Impressive Efficacy
No harmful side effects
A 50% Reduction in Medication Use, including opioidsExceptional Consumer Acceptance
Demonstrated Marketability
An adjunctive or alternative therapy to pain killers, including narcotics
$1+
The bullshit is in the simple post!
Cheers!
$TILLABELIEVER$
$TILLABELIEVER$$
.10+
Lets here about progress on the FDA manufacturing "Tasks"! JMO the operating procedures, manual and run report together with samples with the video chronology of production runs is an easy fix!
$5-$10+
Easy answer could be our product was dated and we (I) cannot confirm the product was actually shipped to Ukraine. Lets see the pr but the FDA is looking for fresh run reports and quality control measures are quantified and verfiable. Hope it Just a "Task'? "to accomplish these remaining Tasks"
$5-$10+
$TILLABELIEVER$ Thanks for bringing this understanding to the board even more then exists in longtime investors!
$.10+
FDA has approved the efficacy of the Actipatch!
$TILLABELIEVER$
$.10+
$TILLABELIEVER$
$.10+
Biel is on the verge of greatness with the upgrade new App technology that will enable auto on/off function with data security and rechargeable features.
$TILLABELIEVER$
Stay the course! Newbies do your d/d. FDA approved the efficacy of the Actipatch hemostyp device for a reason. Electroceuticals are the future! Our chief engineer John Martinez recently completed a new product design!
$TILLABELIEVER$
KN appears pumped to hold the live investor teleconference call. So IMO this is a new product roll out and/or order.
$TILLABELIEVER$
Buy this game changing product!
$5-$10+
https://www.unitedhealthproductsinc.com/
Cats out of the bag on the coming news? John Martinez with his numerous patents using electroceutical products is a valuable asset to the company! With the assumption that a new patent will be issued many must be convinced it will enhance or exceed current product appeal. In other words Actipatch sales will increase.
I/'m still buying!!!
$TILLABELIVER$
$TILLABELIEVER$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
$.10+
Another 20k picked up today for 400K+.
$5-$10+